Disease Response with the Addition of Platinum-Based Chemotherapy to Pembrolizumab after Progression on Pembrolizumab Monotherapy in PD-L1-Expressing Non-Small Cell Lung Cancer. Article uri icon

Overview

publication date

  • August 1, 2018

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • B7-H1 Antigen
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Identity

Scopus Document Identifier

  • 85050212209

Digital Object Identifier (DOI)

  • 10.1016/j.jtho.2018.02.031

PubMed ID

  • 30049372

Additional Document Info

volume

  • 13

issue

  • 8